Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Immune cell therapies and immune cell engineering

Short report

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

Online download statistics by month:

Online download statistics by month: August 2020 to May 2022

	Abstract	Full	Pdf
Aug 2020	170	169	61
Sep 2020	146	146	33
Oct 2020	71	72	29
Nov 2020	68	68	22
Dec 2020	73	73	17
Jan 2021	133	133	33
Feb 2021	103	103	34
Mar 2021	104	104	20
Apr 2021	97	97	26
May 2021	57	57	17
Jun 2021	59	59	12
Jul 2021	46	46	35
Aug 2021	42	42	30
Sep 2021	49	49	28
Oct 2021	54	54	55
Nov 2021	56	56	38
Dec 2021	44	48	23
Jan 2022	60	72	38
Feb 2022	63	68	39
Mar 2022	57	61	30
Apr 2022	75	81	25
May 2022	80	82	17
Total	1707	1740	662